JPMorgan Starts Luminex (LMNX) at Neutral
More News related to LMNX
- Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
- Thomas Weisel Downgrades Luminex (LMNX) to Market Weight
- Luminex Corporation to Present at Canaccord Adams Global Growth Conference
- Luminex (LMNX) Reports Q2 In-Line
- Luminex Corporation Reports Second Quarter 2008 Results
JPMorgan initiates coverage on Luminex Corporation (Nasdaq: LMNX) with a Neutral rating.
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for applications in the life sciences industry.
Related Categories
New CoverageStocks Mentioned
-0.03Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
